An Exploratory Study to Evaluate the Effects of Roflumilast on Insulin Sensitivity and Metabolic Parameters in Prediabetic Overweight and Obese Individuals

Trial Profile

An Exploratory Study to Evaluate the Effects of Roflumilast on Insulin Sensitivity and Metabolic Parameters in Prediabetic Overweight and Obese Individuals

Completed
Phase of Trial: Phase I/II

Latest Information Update: 25 Oct 2017

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Obesity; Prediabetic-state
  • Focus Pharmacodynamics
  • Most Recent Events

    • 26 Jul 2017 Status changed from recruiting to completed.
    • 07 Apr 2017 Planned primary completion date changed from 30 Mar 2017 to 30 Sep 2018.
    • 02 Aug 2016 Planned End Date changed from 1 Sep 2016 to 1 Sep 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top